These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 31125707)
1. Prognostic significance of elevated pre-treatment serum CA-125 levels in patients with stage I ovarian sex cord-stromal tumors. Nasioudis D; Wilson E; Mastroyannis SA; Latif NA Eur J Obstet Gynecol Reprod Biol; 2019 Jul; 238():86-89. PubMed ID: 31125707 [TBL] [Abstract][Full Text] [Related]
2. Role of adjuvant chemotherapy in the management of non-granulosa cell ovarian sex cord-stromal tumors. Nasioudis D; Orfanelli T; Frey MK; Chapman-Davis E; Caputo TA; Witkin SS; Holcomb K J Gynecol Oncol; 2019 Mar; 30(2):e19. PubMed ID: 30740951 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of lymph node metastasis and prognostic significance of lymphadenectomy in apparent early-stage malignant ovarian sex cord-stromal tumors. Nasioudis D; Kanninen TT; Holcomb K; Sisti G; Witkin SS Gynecol Oncol; 2017 May; 145(2):243-247. PubMed ID: 28292524 [TBL] [Abstract][Full Text] [Related]
4. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis. Wang J; Li J; Chen R; Lu X Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women. Zhang M; Cheung MK; Shin JY; Kapp DS; Husain A; Teng NN; Berek JS; Osann K; Chan JK Gynecol Oncol; 2007 Feb; 104(2):396-400. PubMed ID: 17030354 [TBL] [Abstract][Full Text] [Related]
6. Preoperative Differentiation of Benign and Malignant Non-epithelial Ovarian Tumors: Clinical Features and Tumor Markers. Gomes TA; Campos EA; Yoshida A; Sarian LO; Andrade LALA; Derchain SF Rev Bras Ginecol Obstet; 2020 Sep; 42(9):555-561. PubMed ID: 32992358 [TBL] [Abstract][Full Text] [Related]
7. Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology. Bilici A; Inanc M; Ulas A; Akman T; Seker M; Babacan NA; Inal A; Bal O; Koral L; Sevinc A; Tufan G; Elkiran ET; Ustaalioglu BB; Yavuzsen T; Alkis N; Ozkan M; Gumus M Asian Pac J Cancer Prev; 2014 Jan; 14(11):6493-9. PubMed ID: 24377556 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of lymphadenectomyin malignant ovarian sex cord stromal tumor: A retrospective cohort study and meta-analysis. Cheng H; Peng J; Yang Z; Zhang G Gynecol Oncol; 2018 Jan; 148(1):91-96. PubMed ID: 29107349 [TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of serum CA(125) level change during chemotherapy post-surgery in patients with advanced epithelial ovarian carcinoma]. Lan CY; Huang H; Liu JH Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):732-6. PubMed ID: 19087537 [TBL] [Abstract][Full Text] [Related]
10. [Sclerosing stromal tumor of the ovary associated with a Meigs' syndrome and pregnancy: a case report]. Gomes Sobrinho DB; Vasconcelos RG; Carvalho BR; Furtado VM; Ramos FA; Silva Netto JP; Freitas MA Rev Bras Ginecol Obstet; 2013 Jul; 35(7):331-5. PubMed ID: 24080846 [TBL] [Abstract][Full Text] [Related]
11. Feto-maternal outcomes of pregnancy complicated by ovarian sex-cord stromal tumor: a systematic review of literature. Blake EA; Carter CM; Kashani BN; Kodama M; Mabuchi S; Yoshino K; Matsuo K Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():1-7. PubMed ID: 24439718 [TBL] [Abstract][Full Text] [Related]
12. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis. Chan JK; Zhang M; Kaleb V; Loizzi V; Benjamin J; Vasilev S; Osann K; Disaia PJ Gynecol Oncol; 2005 Jan; 96(1):204-9. PubMed ID: 15589602 [TBL] [Abstract][Full Text] [Related]
13. Safety of Fertility-Sparing Surgery for Premenopausal Women With Sex Cord-Stromal Tumors Confined to the Ovary. Nasioudis D; Frey MK; Chapman-Davis E; Witkin SS; Holcomb K Int J Gynecol Cancer; 2017 Nov; 27(9):1826-1832. PubMed ID: 28930803 [TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Prognostic Prediction Model for Postoperative Ovarian Sex Cord-Stromal Tumor Patients. You D; Zhang Z; Cao M Med Sci Monit; 2020 Sep; 26():e925844. PubMed ID: 32943602 [TBL] [Abstract][Full Text] [Related]
15. Meigs' syndrome with elevated serum cancer antigen 125 levels in a case of ovarian sclerosing stromal tumor. Liou JH; Su TC; Hsu JC Taiwan J Obstet Gynecol; 2011 Jun; 50(2):196-200. PubMed ID: 21791307 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Serum CA19-9 and Perioperative CA-125 Levels in Ovarian Clear Cell Carcinoma. Zhu J; Jiang L; Wen H; Bi R; Wu X; Ju X Int J Gynecol Cancer; 2018 Jul; 28(6):1108-1116. PubMed ID: 29781825 [TBL] [Abstract][Full Text] [Related]
18. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer. Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of germ cell and sex cord-stromal ovarian tumors in pediatric age: 5 years experience. Elashry R; Hemida R; Goda H; Abdel-Hady el-S J Exp Ther Oncol; 2013; 10(3):181-7. PubMed ID: 24416992 [TBL] [Abstract][Full Text] [Related]
20. Sclerosing stromal tumour of the ovary associated with Meigs' syndrome and elevated CA125. Amorim-Costa C; Costa A; Baptista P; Paiva V J Obstet Gynaecol; 2010; 30(7):747-8. PubMed ID: 20925634 [No Abstract] [Full Text] [Related] [Next] [New Search]